Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1

Ge Yang; Ziyue Li; Irfan Mohammed; Liping Zhao; Wei Wei; Haihua Xiao; Weisheng Guo; Yongxiang Zhao; Feng Qu; Yuanyu Huang

doi:10.1038/s41392-021-00649-6

Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1

Ge Yang, Ziyue Li, Irfan Mohammed, Liping Zhao, Wei Wei, Haihua Xiao, Weisheng Guo, Yongxiang Zhao, Feng Qu, Yuanyu Huang^*

^*此作品的通讯作者

前沿交叉科学研究院

科研成果: 期刊稿件 › 快报 › 同行评审

67 引用（Scopus）

源语言	英语
文章编号	227
期刊	Signal Transduction and Targeted Therapy
卷	6
期	1
DOI	https://doi.org/10.1038/s41392-021-00649-6
出版状态	已出版 - 12月 2021

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1038/s41392-021-00649-6

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{56e380e2ba8c446da0e4d6d2fbc6fa7d,

title = "Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1",

author = "Ge Yang and Ziyue Li and Irfan Mohammed and Liping Zhao and Wei Wei and Haihua Xiao and Weisheng Guo and Yongxiang Zhao and Feng Qu and Yuanyu Huang",

year = "2021",

month = dec,

doi = "10.1038/s41392-021-00649-6",

language = "English",

volume = "6",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Identification of SARS-CoV-2-against aptamer with high neutralization activity by blocking the RBD domain of spike protein 1

AU - Yang, Ge

AU - Li, Ziyue

AU - Mohammed, Irfan

AU - Zhao, Liping

AU - Wei, Wei

AU - Xiao, Haihua

AU - Guo, Weisheng

AU - Zhao, Yongxiang

AU - Qu, Feng

AU - Huang, Yuanyu

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85107492436&partnerID=8YFLogxK

U2 - 10.1038/s41392-021-00649-6

DO - 10.1038/s41392-021-00649-6

M3 - Letter

C2 - 34112756

AN - SCOPUS:85107492436

SN - 2095-9907

VL - 6

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 227

ER -